16 September
2024
HeiQ Plc
("HeiQ"
or the "Company" or the "Group")
Director's
Dealings
HeiQ Plc (LSE: HEIQ), a leading
company in materials innovation and hygiene technologies, announces
that Carlo Centonze, Chief Executive Officer, has purchased
1,000,000 ordinary shares of 5p each in the Company ("Ordinary
Shares") at a price of 5p per share.
Further information is set out below
pursuant to the requirements of the UK Market Abuse
Regulation.
|
1
|
Details of the person
discharging managerial responsibilities / person closely
associated
|
|
a)
|
Name
|
Mr. Carlo Centonze
|
|
2
|
Reason for the
notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial
notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer,
emission allowance market participant, auction platform, auctioneer
or auction monitor
|
|
a)
|
Name
|
HeiQ plc
|
|
b)
|
LEI
|
213800IGT65IMJDO4S03
|
|
4
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
|
|
a)
|
Description
of the financial instrument, type of instrument
Identification code
|
Ordinary
shares of 5p each
ISIN:
GB00BN2CJ299
|
|
b)
|
Nature of
the transaction
|
Purchase of ordinary
shares
|
|
c)
|
Price(s)
and volume(s)
|
|
Date
|
Price(s)
|
Volume(s)
|
|
12 September 2024
|
5p per share
|
500,000
|
|
13 September 2024
|
5p per share
|
500,000
|
|
|
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
1,000,000
shares
5p per
share
|
|
e)
|
Date of the
transaction
|
12th and 13th
of September 2024
|
|
f)
|
Place of
the transaction
|
London Stock Exchange, Main
Market
|
For
further information, please contact:
|
HeiQ Plc
Carlo Centonze (CEO)
|
+41 56 250 68 50
|
|
Cavendish Capital Markets Limited (Broker)
Stephen Keys / Callum
Davidson
|
+44 (0) 207 397 8900
|
|
SEC
Newgate (Media Enquiries)
Elisabeth Cowell / Molly Gretton /
Tom Carnegie
|
+44 (0) 20 3757 6882
HeiQ@secnewgate.co.uk
|
About HeiQ
Founded in 2005, HeiQ is a
Swiss-based international company that is a global leader in
biotech ingredients and specialty chemicals for diverse
applications such as textiles, flooring, building materials, glass,
plastics, probiotic cleaning, cosmetics, and more. Working with
more than 1000 partners in over 60 countries, our goal is to infuse
ordinary products with extraordinary qualities, offering our
co-creation partners sustainable and disruptive solutions across
industries.
Our business model focuses on the
commercialization of existing and as well as the incubation of new
technologies, driving shareholder value through sales growth, entry
into lucrative markets, and disruptive innovation. This model
consists of three distinct technology ventures, being HeiQ AeoniQ,
HeiQ Xpectra, and HeiQ GrapheneX, and three growth-orientated
business units being HeiQ Textiles & Flooring, HeiQ Life
Sciences, and HeiQ Antimicrobials.
We have a robust track record of
innovation, with over 200 technologies developed in partnership
with 300 major brands, including Hanes, Burberry, HUGO BOSS, Lycra,
Zara, Itochu, Bosch Siemens, Ecolab, Woellner, Americhem, Lixil,
and many more. Our global team comprises about 200 professionals
from 30 nationalities across five continents. We're committed to
shaping a future where everyday products drive positive change, one
innovation at a time.
To learn more about HeiQ and our
innovative solutions, visit www.heiq.com.